Allison R. Hanaford

The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice

Lee J. Martin, Samantha Semenkow, Allison R. Hanaford et al. · Neurobiology of Aging · 2013 · 115 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Synaptic Signaling +9

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma

Allison R. Hanaford, Jesse Alt, Rana Rais et al. · Translational Oncology · 2019 · 72 citations · Full text

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with <i>In Silico</i> Analysis to Identify Novel Therapeutic Targets

Allison R. Hanaford, Tenley C. Archer, Antoinette Price et al. · Clinical Cancer Research · 2016 · 67 citations · Full text

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine

Sabrina Wang, Brad Poore, Jesse Alt et al. · Clinical Cancer Research · 2019 · 32 citations · Full text

Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways

Khoa Pham, Allison R. Hanaford, Brad Poore et al. · Cancers · 2022 · 20 citations · Full text